Skip to main content Accessibility help

Acute viral myocarditis: role of immunosuppression: a prospective randomised study

  • Kalim U. Aziz (a1), Najma Patel (a1), Tareen Sadullah (a1), Habiba Tasneem (a1), Hasina Thawerani (a1) and Saeed Talpur (a1)...



To conduct a prospective randomised study to show the efficacy of immune suppression with prednisolone, administered at the 3-month duration of acute myocarditis.


The diagnosis of acute viral myocarditis was made based on echocardiography and serum viral antibodies. The inclusion criterion was acute myocarditis of 3 months duration. In all, 68 of 173 children were available for randomisation into a prednisolone-treated group of 44 and a control group of 24 children. The follow-up period in the prednisolone-treated group was 15.1 plus or minus 9.2 months and 13.6 plus or minus 10.6 months for the control group.


Compared with controls, 1 month after randomisation significantly more children in the prednisolone-treated group increased their ejection fraction to more than 40% (p = 0.029). Discrete analysis of change in the ejection fraction from the one at randomisation to one after 1 month of randomisation of greater than 10% and less than 10% or no change between groups showed a significantly greater number with improvement in the prednisolone-treated group (p = 0.019). At the end of the follow-up visits, a significantly larger number of children in the prednisolone-treated group had an ejection fraction of more than 60% compared with the control group (p = 0.049).


It is concluded that immune suppression with prednisolone, administered at 3 months of the onset of acute myocarditis, is effective in significantly bringing about improvement and cure in persistent left ventricular failure.


Corresponding author

Correspondence to: K. U. Aziz, Professor Emeritus of Paediatric Cardiology, Department of Paediatric Cardiology, National Institute of Cardiovascular Diseases, Rafiqui (H.J.) Shaheed Road, Karachi, Pakistan. Tel: 92 21 586 6091; Fax: 92 21 920 1287; E-mail:


Hide All
1. Aziz, KU. Acute myocarditis in children, incidence, treatment and prognosis. A developing world problem. Pak Paed Cardiolo J 2001; 3: 121126.
2. Younas, M, Rathore, AW, Sadiq, M. Acute myocarditis – the commonest cause of cardiac failure in children. Pak Paed J 2003; 27: 6367.
3. Chan, KY, Iwahara, M, Benson, LN, Wilson, GJ, Freedom, RM. Immune suppressive therapy in the management of acute myocarditis in children:a clinical trial. J Am COll Cardiol 1991; 17: 458460.
4. Why, HJF, Meany, BT, Richardson, PJ, et al. Clinical and Prognostic significance of detection of Entero virus RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1999; 89: 25822589.
5. Lee, K, McCrindle, B, Bohn, D, et al. Clinical outcome of acute myocarditis in children. Heart 1999; 82: 226233.
6. English, RF, Janosky, JE, Ettedgui, JA, Webber, SA. Outcome of children with acute myocarditis. Cardiol Young 2004; 14: 448493.
7. Nugent, AW, Daubeny, PEF, Chondros, P, et al. Epidemiology of childhood cardiomyopathy in Australia. New Engl J Med 2003; 348: 16391646.
8. Burch, M. Immunosuppressive treatment in pediatric myocarditis Scanty Evidence. Heart 2000; 90: 11031104.
9. McCarthy, RE, Boehmer, JP, Hruban, RH, et al. Long term outcome of Fulminant as compared to acute (non fulminant) Myocarditis. New Engl J Med 2000; 342: 690695.
10. Spotnitz, MD, Lesch, M. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis Historical analysis, review of the literature and postulated unifying hypothesis. Prog Cardiovasc Diseases 2006; 49: 4257.
11. Schultheiss, HP, Kuhl, U. Over view on chronic viral cardiomyopathy. Earnest Shering Res Found Workshop 2006; 55: 318.
12. Ciszewski, A, Bilinska, ZT, Lubiszewska, B, et al. Dilated cardiomyopathy in children clinical course and prognosis. Pediatr cardiol 1994; 15: 121126.
13. Balaji, S, Wiles, HB, Sens, MA, Gillette, PC. Immunosuppressive treatment for myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994; 72: 354359.
14. Ino, T, Okubo, M, Akimoto, K, Nishimoto, K, Yabutak Kawais, S, Okada, R. Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pedtiatr 1995; 126: 304308.
15. Liu, PP, Mason, JW. Advances in the understanding of myocarditis. Circulation 2001; 104: 10761082.
16. Kawai, C. From myocarditis to Cardiomyopathy. Mechanism of inflammation and cell death. Circulation 1999; 99: 10911100.
17. Feldman, AM, McNamara, D. Myocarditis. New Engl J Med 2000; 343: 13881398.
18. Mason, JW, Billingham, ME, Ricci, DR, et al. Treatment of acute inflammatory myocarditis associated by endomyocardial biopsy. Am J Cardiol 1980; 45: 10371044.
19. Martin, AB, Webber, S, Fricker, FY, et al. Acute myocarditis rapid diagnosis by PCR in children. Circulation 1994; 90: 330339.
20. Grogan, M, Redfield, MM, Baily, KR, et al. Long term outcome of patients with biopsy proven myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995; 26: 8084.
21. McNamara, DM, Holubkov, R, Starling, RC, et al. Controlled trial of intravenous immunoglobulin in recent onset dilated cardiomyopathy. Circulation 2001; 103: 22542259.
22. Lauer, B, Niederau, C, Kuh, U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 13541359.
23. Fuse, K, Kodoma, M, Okura, Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000; 102: 28292835.
24. Hia, CPP, Yip, BCL, Tai, BC, Quek, SC. Immunosuppressive therapy in acute myocarditis; an 18 year systematic review. Arc Dis Child 2004; 89: 580584.
25. Ducker, NA, Colan, SD, Lewis, AB, et al. Gammaglobulin treatment of acute myocarditis in pediatric population. Circulation 1994; 89: 252257.
26. Takada, H, Kishimoto, C, Hiraoka, Y. Therapy with immunoglobulins suppresses myocarditis in a Murine Coxsakie virus B3 model. Circulation 1995; 92: 160411611.
27. Jones, SR, Herskowitz, A, Aulchins, GM, et al. Effect of immunosuppressive therapy in biopsy proved myocarditis and borderline myocarditis on ventricular function. AM J Cardiol 1991; 68: 370376.
28. Maisch, B, Hafnagel, G, Schonian, U, Hengstenberg, C. The European study of Epidemiology and treatment of cardiac influmatory disease. Eur Heart J 1995; 16: 173175.
29. Levi, D, Alejo, SJ. An approach to the treatment of pediatric myocarditis. Paedtr Drug 2002; 4: 637647.
30. Gagliardi, MG, Bevilacqua, M, Bassono, C, et al. Long term follow up of children and of children with dilated cardiomyopathy. Heart 2004; 90: 11671171.
31. Kuhl, U, Pauschinger, M, Schwimmbeck, P, et al. Interferon beta treatment improves left ventricular function in patients with persistence of viral genome. Circulation 2003; 107: 27932798.
32. Ellis, CR, Di Salvo, T. Myocarditis: basic and clinical aspects. Cardiol Rev 2007; 15: 170177.
33. Matsumori, A, Tomioka, N, Kawai, C. Protective effect of recombinant alpha interferon on Coxsackie B myocarditis in Mice. Am Heart J 1988; 115: 12291232.
34. Ahdoot, J, Galindo, A, Alijos, JC, et al. Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transplant 2000; 19: 11181121.


Acute viral myocarditis: role of immunosuppression: a prospective randomised study

  • Kalim U. Aziz (a1), Najma Patel (a1), Tareen Sadullah (a1), Habiba Tasneem (a1), Hasina Thawerani (a1) and Saeed Talpur (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed